Posts relating to “"biologics"” (134)
Look up
""biologics""
at The Free Dictionary
-
UCSF Physicians Respond to Rep. Eshoo on Evergreening Loophole in …
Firedoglake — Authority 749
Anna Eshoo’s (D-California) co-sponsorship of the biologics legislation now under consideration as part of the overall […] health care reform package weaving its way through Congress (” Eshoo needs to close loophole in biologics legislation “, Dec […] . 2). Rep. Eshoo responded with an op-ed several days later (” Biologics bill will help make breakthrough drugs more2 weeks ago -
A Monopoly on Biologics will Drain Health Care Resources
The Lancet Student — Authority 128
new patenting laws of Biologics in the United States Due to intense pharmaceutical lobbying pressure, a new U.S. bill […] will give biotech companies a twelve-year long monopoly on a class of medicines commonly known as biologics. Reforming […] new U.S. bill will give biotech companies a twelve-year long monopoly on a class of medicines commonly known as biologics2 weeks ago -
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With …
PR News Wire — Authority 867
CAMBRIDGE, Massachusetts, December 22 /PRNewswire-FirstCall/ -- Shire plc(LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,today announced that it has submitted a BLA with the FDA for REPLAGAL(R)(agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGALfirst received ...2 weeks ago -
In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics …
PR News Wire — Authority 867
/Janssen-Cilags Stelara and Abbotts briakinumab (both interleukin inhibitors) will capture 22 percent of the biologics share in 2012 in the3 weeks ago -
Biologics Transform RA Outlook
MedPageToday.com - medical news plus CME for physicians — Authority 654
Rheumatoid arthritis patients no longer face a lifetime of crippling disability, thanks to the introduction of TNF inhibitors as well as better use of methotrexate and disease-monitoring tools.5 days ago -
Medtronic: New Product Should Boost Spinal and Biologics Segment
SeekingAlpha.com: Home Page — Authority 639
Zacks.com submits: Medtronic, Inc. ( MDT ) recently reported the launch of its new product, the SOVEREIGN Spinal System, in the United States. The SOVEREIGN Spinal System is used to treat patients suffering from a degenerative condition affecting the lumbar spine. The new product is an intervertebral body ...1 week ago -
Wall Street Speaks: Eshoo Block Biologics
Forbes.com: Wine News — Authority 658
Try as she might, Rep. Anna Eshoo cant make the laws of competition bend her way.2 weeks ago -
Scientists Are "Reolysin" The Power Of Live Biologics To Fight Cancer …
Health News from Medical News Today — Authority 708
A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard3 weeks ago -
Merck Acquires Contract Manufacturer Avecia as it Positions Itself to …
Bio Job Blog — Authority 128
agreement by which Merck will acquire the biologics business of UK-based Avecia; a contract manufacturing organization with […] specific expertise in microbial-derived biologics. A Merck executive commented on the deal: "At Merck we continue to execute […] initial strategic development and supply relationship with Avecia Biologics and will provide us with an operational facility2 weeks ago -
Inno Biologics, Cevec Pharmaceuticals ink licensing agreement
The Star Online — Authority 759
KUALA LUMPUR: Inno Biologics Sdn Bhd has signed a strategic licensing agreement with Germany’s Cevec Pharmaceuticals4 weeks ago